Actemra 400 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FAXK9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,123
Award facts
- Contract value 100% obligated
- $6,123.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,123.36 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials on May 27, 2025, with an ultimate completion date of May 28, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX) valued at $999.99 billion and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of medications and medical supplies to support military and federal healthcare systems through the DLA Medical Supply Chain. This delivery order for Actemra, a biologic treatment commonly used for rheumatoid arthritis and other inflammatory conditions, exemplifies the company's role in providing specialty pharmaceuticals to federal customers including the Defense Health Agency and U.S. Coast Guard. The firm's status as a primary vendor under the global pharmaceutical prime vendor contract reflects its capability to fulfill federal medical procurement requirements across multiple therapeutic domains on a competitive basis.
Quick answers
Who was awarded contract SPE2DB25FAXK9?
SPE2DB25FAXK9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 27, 2025.
How much is contract SPE2DB25FAXK9 worth?
The government has obligated $6,123 on SPE2DB25FAXK9.
Is contract SPE2DB25FAXK9 an order under another contract?
Yes. SPE2DB25FAXK9 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FAXK9 competed?
The extent of competition for SPE2DB25FAXK9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award